82.11 -1.26 (-1.54%)
UTHR
Stock Details
Last Trade:82.11 Change:-1.26 (-1.54%) Prev Close:83.37 Open: 82.00 Days Range:80.37 – 82.50 52 Week Range: 47.63 - 117.82 Volume:372289 P/E: N/AEPS:-1.84
View AllRecent Alerts 07/04/09
Recent Alert on 05/26/09 at 9:15am
Morning Movers 5/26: MAPP, CYTK, CMM, EMIS, UTHR Higher; SHLO, GM, CSIG, FSLR Lower
Morning Movers 5/26: MAPP, CYTK, CMM, EMIS, UTHR Higher; SHLO, GM, CSIG, FSLR Lower
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) 133% HIGHER; announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX(TM) orally inhaled migraine therapy met all four primary endpoints. Additional endpoints... Read More
Recent Alert on 05/26/09 at 7:59am
FDA Approves United Therapeutics (UTHR) ADCIRCA Tablets for the Treatment of Pulmonary Arterial Hypertension
FDA Approves United Therapeutics (UTHR) ADCIRCA Tablets for the Treatment of Pulmonary Arterial Hypertension
Recent Alert on 05/26/09 at 7:59am
FDA Approves United Therapeutics (UTHR) ADCIRCA Tablets for the Treatment of Pulmonary Arterial Hypertension
FDA Approves United Therapeutics (UTHR) ADCIRCA Tablets for the Treatment of Pulmonary Arterial Hypertension
Recent Alert on 05/19/09 at 7:23am
Soleil Securities Initiates Coverage on United Therapeutics (UTHR) with a Buy; Upcoming Catalysts Could Drive Stock Higher
Soleil Securities Initiates Coverage on United Therapeutics (UTHR) with a Buy; Upcoming Catalysts Could Drive Stock Higher
Recent Alert on 05/04/09 at 5:42pm
Auriga Initiates Coverage on United Therapeutics (UTHR) with a Buy
Auriga Initiates Coverage on United Therapeutics (UTHR) with a Buy
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/19/09 at 7:14am
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline